NCT06155838

Brief Summary

The objective of this clinical trial is to assess the efficacy of the Early Adolescent Skills for Emotions (EASE) program, a school-based, non-specialist psychosocial intervention developed by the WHO for LMICs, in alleviating Anxiety and Depression among teens aged 13-19. The primary inquiries it seeks to address include: Does the EASE intervention effectively reduce anxiety and depression scores 12 weeks after implementation?

  • Can the EASE intervention enhance quality of life, improve problem-solving skills, and increase perceived emotional support?
  • Is the EASE intervention beneficial for enhancing the psychological well-being of parents and fostering positive parent-teen relationships?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

November 27, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 5, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

February 3, 2025

Status Verified

January 1, 2025

Enrollment Period

4 months

First QC Date

April 17, 2023

Last Update Submit

January 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aga Khan University Anxiety and Depression Scale (AKUADS-25)

    AKUADS will be used to assess anxiety and depression affecting the target population. Items score ranges from 0-3 (0= never, 1=sometime, 2=mostly, 3=always) for each question item hence the total score of the tool is 0-75. The higher the score the more anxiety and depression will be severe with the cut score of 19.

    at 12 weeks' post-intervention

Secondary Outcomes (8)

  • The Kessler Psychological Distress Scale -10 (K-10)

    at 12 weeks' post-intervention

  • The Perceived Emotional/Personal Support Scale ( PEPSS)

    at 12 weeks' post- intervention

  • The Social Problem-Solving Inventory-Revised Short Form- 25

    at 12 weeks' post- intervention

  • Parent-rated Pediatric Quality of Life (PedsQL).

    at 12 weeks' post- intervention

  • Parenting practices

    at 12 weeks' post- intervention

  • +3 more secondary outcomes

Study Arms (2)

EASE Intervention

EXPERIMENTAL

The intervention consists of four fundamental themes that have empirical support, structured across seven group sessions for adolescents and three group sessions for their parents or guardians. The sessions for teenagers will be conducted in person, spanning seven weeks with one session per week, each lasting 90 minutes. Similarly, three sessions are scheduled for parents. In accordance with WHO guidelines (2016), the intervention will be administered by non-specialist co-facilitators(class teachers) who possess at least 16 years of education (undergraduate degree). These co-facilitators will undergo a ten-day training program, demonstrating mock sessions as part of this training. During the intervention delivery, they will also benefit from weekly supervision provided by a specialist, who will be a graduate psychologist or trained nurse in mental health.

Other: "Early Adolescent Skills for Emotions (EASE)

control/ wait list

NO INTERVENTION

Throughout the study, participants in the control group will continue to receive standard treatment. Nevertheless, following the conclusion of the trial, all control group participants will undergo the EASE intervention over a seven-week period, which will also involve three sessions for their parents and guardians. This approach ensures that the control group is not placed at a disadvantage, in alignment with ethical principles.

Interventions

Weekly Schedule for Teen's and their parents Sessions: Over the course of 7 sessions, with one session per week lasting 90 minutes, the following core components will be covered: Week 1: Exploring My Feelings Week 2: Learning to Calm Week 3 \& 4: Learning CBT- Restructuring My Thinking, Changing Feelings and My Actions \& Managing My Emotions and Issues Week 5 \& 6: Fostering Independent Problem-Solving Skills and Seeking Help Week 7: Relapse Prevention 2.0 For parents/ guardians Week 3 Psychoeducation (to develop skills to be able to identify, listen, better respond and provide comfort to teens when they are overwhelmed by anxiety and depression). Week 4 Positive parenting strategies Week 5 Parents/ guardians Self-care

EASE Intervention

Eligibility Criteria

Age13 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Teens aged 13-19 years
  • Living with parents/primary caregivers
  • Enrolled in public middle and high schools of Multan, Southern Punjab, Pakistan
  • Teens Assent - agreed and signed by teen
  • Informed consent from parents- agreed and signed by parents

You may not qualify if:

  • Teens part of a dysfunctional family
  • Psychiatric issues
  • Physical and sensory disorder diagnosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Office of the Chief Executive Officer, District Education Authority, Multan

Multan Khurd, Punjab Province, Pakistan

Location

Related Publications (1)

  • Ghazal L, Cui N, Cao F. To evaluate the EASE intervention for reducing anxiety and depression among adolescents in Pakistan: a protocol for a mixed methods study, including a cluster-randomised controlled trial. BMJ Open. 2025 Mar 22;15(3):e086393. doi: 10.1136/bmjopen-2024-086393.

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Lubna Ghazal

    Aga Khan University

    PRINCIPAL INVESTIGATOR
  • Coa Fenglin

    Shandong University - China

    STUDY CHAIR
  • Cui Naixue

    Shandong University - China

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

April 17, 2023

First Posted

December 5, 2023

Study Start

November 27, 2023

Primary Completion

March 31, 2024

Study Completion

March 31, 2024

Last Updated

February 3, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

As mentioned below.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
June 2026- December 2026
Access Criteria
Anyone with a reasonable reason

Locations